Articles

Podcasts

Videos

Clinical

Rates of hepatitis C reinfection were low among people receiving opioid agonist therapy, according to a new study, which highlights the importance of risk reduction interventions and HCV treatment for people who inject drugs and people receiving opioid agonist therapy.

HCV Reinfection Rare Among Patients Receiving Opioid Agonist Therapy

WHO guidelines on HIV, hepatitis and STIs focus on populations with high risk of infections but low inclusion in prevention and treatment programs.

WHO Provides Guidelines on HIV, Hepatitis and STIs in Key Populations

WHO issues new HCV treatment recommendations that include "radical simplification" of care pathways, in pursuit of testing and treatment goals.

WHO Updates HCV Recommendations in Pursuit of 2030 Goals

At AIDS 2022, Gilead presented data suggesting Biktarvy was a safe and effective complete HIV treatment regimen, including for those coinfected with hepatitis B.

Biktarvy Effective for HIV Patients Coinfected With Hepatitis B

Implicating adenovirus for hepatitis of unknown cause in children is confounded by its absence in some cases, and from all tested hepatic tissue.

Association of Adenovirus with Hepatitis of Unknown Cause in Children

Viral hepatitis “can and should be managed within primary care,” says Dr. Thomas Robertson.

“Increased Screening, More Outreach, More Support”: Ending Viral Hepatitis

2 patients died of Marburg virus in the southern Ashanti region of Ghana. Nearly 100 close contacts are now under observation for the infectious disease, which is a cousin of the Ebola virus. 

Ghana Confirms Multiple Cases of Deadly Marburg Virus

The investigational therapy’s data points to a path towards a potential functional cure. 

GSK Reports Phase 2B Results on Bepirovirsen for Chronic Hepatitis B Treatment   

A shorter dosing period and no extra risk of suffering acute myocardial infarction means the newer 2-dose hepatitis B vaccine is an attractive option for protection.

Two-Dose Hepatitis B Vaccine No More Likely to Result in Cardiac Event

The cases are in the pediatric population and come from 11 countries in the WHO European Region and 1 country in the WHO Region of the Americas.

BLOOD-BORNE DISEASES

Latest News